Page last updated: 2024-10-16

adenine and B-Cell Prolymphocytic Leukemia

adenine has been researched along with B-Cell Prolymphocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Moore, J1
Baran, AM1
Meacham, PJ1
Evans, AG1
Barr, PM1
Zent, CS1
Oka, S1
Ono, K1
Nohgawa, M1
George, P1
Brown, A1
Weinkove, R1
Damlaj, M1
Al Balwi, M1
Al Mugairi, AM1
Patil, N1
Went, RG1

Other Studies

5 other studies available for adenine and B-Cell Prolymphocytic Leukemia

ArticleYear
Initial treatment of B-cell prolymphocytic leukemia with ibrutinib.
    American journal of hematology, 2020, Volume: 95, Issue:5

    Topics: Adenine; Aged; Female; Humans; Leukemia, Prolymphocytic, B-Cell; Male; Piperidines; Pyrazoles; Pyrim

2020
Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia.
    Investigational new drugs, 2020, Volume: 38, Issue:5

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antineoplastic Agents; Humans; Leukemia, Prolymp

2020
B-cell prolymphocytic leukaemia with a t(4;14) FGFR3/IGH translocation: response to ibrutinib.
    Pathology, 2020, Volume: 52, Issue:4

    Topics: Adenine; Aged; Antineoplastic Agents; Humans; Leukemia, Prolymphocytic, B-Cell; Male; Piperidines; R

2020
Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:3

    Topics: Adenine; Aged; Gene Rearrangement; Humans; Leukemia, Prolymphocytic, B-Cell; Male; Piperidines; Prog

2018
Venetoclax is an option in B-cell prolymphocytic leukaemia following progression on B-cell receptor pathway inhibitors.
    British journal of haematology, 2019, Volume: 186, Issue:4

    Topics: Adenine; Aged; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Drug Substitution; Hu

2019